The presentation of the Multiparametric Microscopic and Functional Analysis for the Screening of Pharmaceutical Compounds was conducted with interest, as part of the completion of the Scientific Project “DiseasePHENOTarget,” on 8/10/2025 at the Hellenic Pasteur Institute. The Scientific Project “DiseasePHENOTarget” is a project funded by the Hellenic Foundation for Research and Innovation (HFRI) (ELIDEK-2019) under the Scientific Guidance of the Researcher of the Hellenic Pasteur Institute, Project lead, Dr. Rebecca Matsas at the Laboratory of Cellular and Molecular Neurobiology – Stem Cells.
Within the framework of this project, the capabilities of the equipment acquired by the laboratory, which constitutes this platform, were presented: the Zeiss Celldiscoverer 7 microscopy and imaging device, and the Axion in vitro Microelectrode Array (MEA) device.
Following this, the research results utilizing the above equipment within the project were presented for the screening of pharmaceutical molecules by Dr. Erasmia Taoufik, Senior Researcher of the Laboratory, and the study of the pathophysiology of Parkinson’s Disease by Dr. Florentia Papastefanaki, Research Staff Scientist, Grade Α of the Laboratory and Head of the Human Embryonic and Induced Pluripotent Stem Cell Unit of the Institute.
This platform represents a significant acquisition for the Laboratory and the Hellenic Pasteur Institute and can serve as a scientific hub for the development of new research collaborations within the Institute as well as among Research Centers, infrastructures, and Universities across the country, with the goal of further advancing scientific knowledge in a broad range of the fields of Neuroscience and Biosciences.
Dr. R. Matsas (left), Dr. E. Taoufik (center), and Dr. F. Papastefanaki (right).
Mr. Anastasios Kollias, Staff Scientist of the Human Embryonic and Induced Pluripotent Stem Cell Unit with Zeiss Celldiscoverer 7 device (left) and the Axion MEA device (right).